Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From this morning news release

From this morning news release

posted on Oct 23, 2007 08:43AM

The WallSt interview will also cover Patriot's growing licensing portfolio, Turley's views on Patriot's current stock valuation and his vision for the company in the next 12 to 18 months, among other topics.

12 to 18 months is nothing for a new CEO to get rolling.  Look at what he has done already in 4 mos. (share buy back, warrant removal, key new hires) 

"Growing licensing portfolio" sounds like a hint to me.   What else will me announced later today?

For those of you that like to complain about everything and are in a hurry for everything.... Your "Nervous Nelly" personality is annoying.  Find something else meaningful in your life would you.

Thanks in advance for those of you willing to share todays meeting details.

GLTA  

Share
New Message
Please login to post a reply